Searched for
GASTROESOPHAGEAL REFLUX
Acidity and heartburn very often? Harvard-trained doctor has 5 easy remedies to improve your digestive healthHeartburn and acid reflux are common digestive issues often triggered by diet and lifestyle. Gastroenterologist Dr. Saurabh Sethi suggests ...
Esophageal cancer or GERD? The overlapping symptoms, and the one thing that sets them apartHeartburn is common, but persistent chest discomfort or difficulty swallowing could signal serious issues. Gastroesophageal reflux disease,...
Suffering from heartburn? AIIMS-trained gastro doctor 4 natural remedies for acid refluxAcid reflux, or heartburn, occurs when stomach acid flows back into the esophagus due to a weakened lower esophageal sphincter (LES). Commo...
Struggling with burning chest? Harvard-trained gastroenterologist recommends 4 natural beverages to stop acid reflux without medicationAcid reflux discomfort can be managed with natural remedies. Dr Saurabh Sethi, a gastroenterologist, shared simple lifestyle changes and fo...
Silent symptom of cancer that millions live with, without realising. When should you visit doctor?A common condition like acid reflux is often dismissed as harmless, but doctors are warning that persistent symptoms could point to esophag...
Zydus inks licensing pact with Takeda to sell GERD drug"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...
Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in IndiaMankind Pharma partners with Takeda to introduce Vonoprazan for GERD, oesophagitis, ulcers, and Helicobacter pylori in India. EVP Ramesh st...
Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in IndiaSun Pharma and Cipla have entered a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India. This novel drug...
Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
Prolong use of gastroesophageal reflux medications raises risk of dementia, says studyThe study's findings underscore the potential risks associated with prolonged use of proton pump inhibitors and its potential link to demen...
Cipla gets USFDA nod for generic acid reflux drugThe company has received final approval for its abbreviated new drug application (ANDA) for Esomeprazole for oral suspension in the strengt...
Suffering from a persistent cough? Giving up on chocolate, mint may helpGastroesophageal reflux disease may often lead you to believe that it is a persistent throat problem, while the cause lies in your stomach.
Strides Shasun gets USFDA tentative nod for Ranitidine tabletsIn a BSE filing, Strides Shasun said "it has received approval from the US Food and Drug Administration (USFDA) for Ranitidine tablets USP,...
Aurobindo Pharma gets USFDA nod for gastro reflux drugThe company said the launch of the product is based on the settlement terms/litigation outcome with AstraZeneca.
Aurobindo Pharma gets final USFDA nod for gastro reflux drugAurobindo Pharma has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the trea...
Aurobindo Pharma gets USFDA nod for acid reflux treatment drugAurobindo Pharma has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux...
Lupin launches generic GERD drug in the US marketUsed to treat gastroesophageal reflux disease.
Indian companies in FDA's first list for generic Aciphex tabletsIndian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic vers...
Zydus receives anti-hypertensive drug approvalZydus Cadila has received tentative approval from the US drug authorities for two anti-hypertensive drugs.
- Zydus Cadila gets USFDA nod for anti-peptic ulcer injection
The company has now 76 approvals and has so far filed 172 abbreviated new drug applications since the filing process began in 2003-04, it a...